서울대학교 중앙도서관

S-Space 소개

My S-Space

로그인이 필요합니다.

Login

S-Space

Browse

Author

Jump to a point in the index

Or type in a year

Sort by
In order
Results/Page
Authors/record

Showing results 1 to 6 of 6

Issue Date	Title / Author(s) / Citation	File	Altmetrics
2017-10	A first-time-in-human study of GSK2636771, a phosphoinositide 3 kinase beta-selective inhibitor, in patients with advanced solid tumors Mateo, Joaquin; Ganji, Gopinath; Lemech, Charlotte; Burris, Howard A.; Han, Sae-Won; Swales, Karen; Decordova, Shaun; DeYoung, M. Phillip; Smith, Deborah A.; Kalyana-Sundaram, Shanker; Wu, Jiuhua; Motwani, Monica; Kumar, Rakesh; Tolson, Jerry M.; Rha, Sun Young; Chung, Hyun Cheol; Eder, Joseph P.; Sharma, Sunil; Bang, Yung-Jue; Infante, Jeffrey R.; Yan, Li; de Bono, Johann S.; Arkenau, Hendrik-Tobias Clinical Cancer Research, Vol.23 No.19, pp.5981-5992	DOI
2019-02	Avelumab (anti-PD-L1) as first-line switch-maintenance or second-line therapy in patients with advanced gastric or gastroesophageal junction cancer: phase 1b results from the JAVELIN Solid Tumor trial Chung, Hyun Cheol; Arkenau, Hendrik-Tobias; Lee, Jeeyun; Rha, Sun Young; Oh, Do-Youn; Wyrwicz, Lucjan; Kang, Yoon-Koo; Lee, Keun-Wook; Infante, Jeffrey R.; Lee, Sung Sook; Kemeny, Margaret; Keilholz, Ulrich; Melichar, Bohuslav; Mita, Alain; Plummer, Ruth; Smith, Denis; Gelb, Arnold B.; Xiong, Huiling; Hong, Janet; Chand, Vikram; Safran, Howard Journal for ImmunoTherapy of Cancer, Vol.7 No.1, p. 30	DOI
2019-02	Avelumab (anti–PD-L1) as first-line switch-maintenance or second-line therapy in patients with advanced gastric or gastroesophageal junction cancer: phase 1b results from the JAVELIN Solid Tumor trial Chung, Hyun Cheol; Arkenau, Hendrik-Tobias; Lee, Jeeyun; Rha, Sun Young; Oh, Do-Youn; Wyrwicz, Lucjan; Kang, Yoon-Koo; Lee, Keun-Wook; Infante, Jeffrey R; Lee, Sung Sook; Kemeny, Margaret; Keilholz, Ulrich; Melichar, Bohuslav; Mita, Alain; Plummer, Ruth; Smith, Denis; Gelb, Arnold B; Xiong, Huiling; Hong, Janet; Chand, Vikram; Safran, Howard Journal for ImmunoTherapy of Cancer. 2019 Feb 04;7(1):30	view file DOI
2023-05	Results from a Phase 1b/2 Study of Ibrutinib Combination Therapy in Advanced Urothelial Carcinoma Mar, Nataliya; Zakharia, Yousef; Falcon, Alejandro; Morales-Barrera, Rafael; Mellado, Begona; Duran, Ignacio; Oh, Do-Youn; Williamson, Stephen K.; Gajate, Pablo; Arkenau, Hendrik-Tobias; Jones, Robert J.; Teo, Min Yuen; Turan, Tolga; McLaughlin, Robert T.; Peltier, Hillary M.; Chong, Elizabeth; Atluri, Harisha; Dean, James P.; Castellano, Daniel Cancers, Vol.15 No.11, p. 2978	DOI
2023-11	Ibrutinib combination therapy for advanced gastrointestinal and genitourinary tumours: results from a phase 1b/2 study Oh, Do-Youn; Maqueda, Maria Alsina; Quinn, David I.; O'Dwyer, Peter J.; Chau, Ian; Kim, Sun Young; Duran, Ignacio; Castellano, Daniel; Berlin, Jordan; Mellado, Begona; Williamson, Stephen K.; Lee, Keun-Wook; Marti, Francisca; Mathew, Paul; Saif, Muhammad Wasif; Wang, Ding; Chong, Elizabeth; Hilger-Rolfe, Jacqueline; Dean, James P.; Arkenau, Hendrik-Tobias BMC Cancer, Vol.23 No.1, p. 1056	DOI
2023-11	Ibrutinib combination therapy for advanced gastrointestinal and genitourinary tumours: results from a phase 1b/2 study Oh, Do-Youn; Maqueda, Maria Alsina; Quinn, David I.; O’Dwyer, Peter J.; Chau, Ian; Kim, Sun Young; Duran, Ignacio; Castellano, Daniel; Berlin, Jordan; Mellado, Begona; Williamson, Stephen K.; Lee, Keun-Wook; Marti, Francisca; Mathew, Paul; Saif, Muhammad W.; Wang, Ding; Chong, Elizabeth; Hilger-Rolfe, Jacqueline; Dean, James P.; Arkenau, Hendrik-Tobias BMC Cancer, Vol.23(1):1056	view file DOI

1